Royal Bank of Canada
CRMD.WS

Royal Bank of Canada’s CORMEDIX INC WTS EXP 04/30/15 CRMD.WS Stock Holding History

Royal Bank of Canada’s Portfolio CRMD.WS Stock Details CRMD.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-100
Closed – – 6374
2013
Q4 		$0 Buy
+100
New +$12 ﹤0.01% 6420

Other funds holding CRMD.WS

AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.35% 1-Year Est. Return

Royal Bank of Canada's CRMD.WS Position: Q1 2014 in Review

Royal Bank of Canada sold out of CORMEDIX INC WTS EXP 04/30/15 (CRMD.WS) in Q1 2014, closing a stake of 100 shares.

Royal Bank of Canada first reported a position in CRMD.WS in Q4 2013 and held it in 1 quarter. The position peaked at $0 in Q4 2013. 3 funds tracked by Wall St. Rank hold CRMD.WS as of Q1 2014.

  • Royal Bank of Canada reported no remaining CORMEDIX INC WTS EXP 04/30/15 position as of Q1 2014 after selling out during the quarter.
  • Royal Bank of Canada sold 100 CORMEDIX INC WTS EXP 04/30/15 shares in Q1 2014.
  • Royal Bank of Canada first reported a position in CORMEDIX INC WTS EXP 04/30/15 in Q4 2013 and held it in 1 quarter.
  • Royal Bank of Canada's CORMEDIX INC WTS EXP 04/30/15 position peaked at $0 in Q4 2013.
  • 3 funds tracked by Wall St. Rank held CORMEDIX INC WTS EXP 04/30/15 as of Q1 2014.

Based on Royal Bank of Canada's 13F filing for Q1 2014, filed 15 May 2014.